Literature DB >> 16820418

Novel Olig 1-coding variants and susceptibility to multiple sclerosis.

A Goris, T W Yeo, M Maranian, A Walton, M Ban, J Gray, A Compston, S Sawcer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16820418      PMCID： PMC2077377          DOI： 10.1136/jnnp.2006.090639

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  5 in total

1.  Myelin repair: developmental myelination redux?

Authors:  Roumen Balabanov; Brian Popko
Journal:  Nat Neurosci       Date:  2005-03       Impact factor: 24.884

2.  Olig1 needed for remyelination.

Authors:  Adrian Burton
Journal:  Lancet Neurol       Date:  2005-02       Impact factor: 44.182

3.  Myelinogenesis and axonal recognition by oligodendrocytes in brain are uncoupled in Olig1-null mice.

Authors:  Mei Xin; Tao Yue; Zhenyi Ma; Fen-fen Wu; Alexander Gow; Q Richard Lu
Journal:  J Neurosci       Date:  2005-02-09       Impact factor: 6.167

Review 4.  Why does remyelination fail in multiple sclerosis?

Authors:  Robin J M Franklin
Journal:  Nat Rev Neurosci       Date:  2002-09       Impact factor: 34.870

5.  bHLH transcription factor Olig1 is required to repair demyelinated lesions in the CNS.

Authors:  Heather A Arnett; Stephen P J Fancy; John A Alberta; Chao Zhao; Sheila R Plant; Sovann Kaing; Cedric S Raine; David H Rowitch; Robin J M Franklin; Charles D Stiles
Journal:  Science       Date:  2004-12-17       Impact factor: 47.728
  5 in total
  2 in total

1.  Delayed onset of experimental autoimmune encephalomyelitis in Olig1 deficient mice.

Authors:  Xiaoli Guo; Chikako Harada; Kazuhiko Namekata; Yoshinori Mitamura; Hiroshi Yoshida; Yoh Matsumoto; Takayuki Harada
Journal:  PLoS One       Date:  2010-09-29       Impact factor: 3.240

Review 2.  Paving the axonal highway: from stem cells to myelin repair.

Authors:  Raniero L Peru; Nicole Mandrycky; Brahim Nait-Oumesmar; Q Richard Lu
Journal:  Stem Cell Rev       Date:  2008-12       Impact factor: 5.739
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.